MX338100B - Celulas derivadas de tejido cardiaco. - Google Patents

Celulas derivadas de tejido cardiaco.

Info

Publication number
MX338100B
MX338100B MX2012000493A MX2012000493A MX338100B MX 338100 B MX338100 B MX 338100B MX 2012000493 A MX2012000493 A MX 2012000493A MX 2012000493 A MX2012000493 A MX 2012000493A MX 338100 B MX338100 B MX 338100B
Authority
MX
Mexico
Prior art keywords
derived cells
cardiac tissue
compositions
present
human cardiac
Prior art date
Application number
MX2012000493A
Other languages
English (en)
Other versions
MX2012000493A (es
Inventor
Xiaozhen Wang
Ian R Harris
Jeffrey S Kennedy
Jing Yang
Susan Munga
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MX2012000493A publication Critical patent/MX2012000493A/es
Publication of MX338100B publication Critical patent/MX338100B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a métodos y composiciones para reparar el miocardio dañado con el uso de células derivadas de tejido cardíaco humano; particularmente, la presente invención proporciona métodos y composiciones para reparar el miocardio dañado con el uso de células derivadas de tejido cardíaco humano expandidas que no expresan telomerasa.
MX2012000493A 2009-07-09 2010-07-08 Celulas derivadas de tejido cardiaco. MX338100B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22444609P 2009-07-09 2009-07-09
PCT/US2010/041327 WO2011005930A1 (en) 2009-07-09 2010-07-08 Cardiac tissue-derived cells

Publications (2)

Publication Number Publication Date
MX2012000493A MX2012000493A (es) 2012-06-01
MX338100B true MX338100B (es) 2016-04-01

Family

ID=43429532

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000493A MX338100B (es) 2009-07-09 2010-07-08 Celulas derivadas de tejido cardiaco.

Country Status (16)

Country Link
US (2) US20110014161A1 (es)
EP (1) EP2451941B1 (es)
JP (1) JP5894071B2 (es)
KR (1) KR101834800B1 (es)
CN (1) CN102712897B (es)
AR (1) AR077309A1 (es)
AU (1) AU2010271394B9 (es)
BR (1) BR112012001107A2 (es)
CA (1) CA2767825A1 (es)
ES (1) ES2679271T3 (es)
MX (1) MX338100B (es)
PL (1) PL2451941T3 (es)
RU (3) RU2642282C1 (es)
SG (2) SG176806A1 (es)
WO (1) WO2011005930A1 (es)
ZA (1) ZA201200949B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9644181B2 (en) * 2012-04-25 2017-05-09 Riken Cell preparation containing myocardium-committed cell
US20140271575A1 (en) * 2013-03-15 2014-09-18 Coretherapix Slu Adult cardiac stem cell population
GB201304831D0 (en) * 2013-03-15 2013-05-01 Coretherapix Slu Adult cardiac stem cell population
ES2689804T3 (es) * 2013-11-20 2018-11-15 Miltenyi Biotec Gmbh Composiciones de subpoblaciones de cardiomiocitos
US20150328263A1 (en) 2014-05-14 2015-11-19 University Of Maryland, Baltimore Cardiac stem cells for cardiac repair

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372872A (ja) * 1988-07-12 1991-03-28 Bio Kagaku Kenkyusho:Kk 無血清培地及びそれを用いた哺乳類細胞の培養法
US5958680A (en) * 1994-07-07 1999-09-28 Geron Corporation Mammalian telomerase
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
WO1998014592A2 (en) * 1996-10-01 1998-04-09 Geron Corporation Telomerase reverse transcriptase
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
AU3112499A (en) * 1998-03-23 1999-10-18 Zymogenetics Inc. Cardiac-derived stem cells
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
JP2000281593A (ja) * 1999-03-30 2000-10-10 Fuji Photo Film Co Ltd 精製有機化合物の製造方法
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20030129745A1 (en) * 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
JP2002078483A (ja) * 2000-06-28 2002-03-19 Takeda Chem Ind Ltd 心筋細胞の調製法および心疾患治療薬の探索法
AU2001284695A1 (en) * 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
JP2004529621A (ja) * 2001-02-14 2004-09-30 ティー ファークト，レオ 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
US20030082153A1 (en) * 2001-10-22 2003-05-01 The Government Of The United States Of America Stem cells that transform to beating cardiomyocytes
JP4330995B2 (ja) * 2001-11-15 2009-09-16 チルドレンズ メディカル センター コーポレーション 絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法
AU2003266282A1 (en) * 2002-07-30 2004-02-23 Tigenix N.V. Compositions comprising muscle progenitor cells and uses thereof
AU2003270051A1 (en) * 2002-08-29 2004-03-19 Baylor College Of Medicine Heart derived cells for cardiac repair
ITRM20030376A1 (it) * 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
CA2540135C (en) * 2003-10-03 2012-12-04 Keiichi Fukuda Method of inducing the differentiation of stem cells into cardiomyocytes
ES2527293T3 (es) * 2004-08-16 2015-01-22 Cellresearch Corporation Pte Ltd Aislamiento de células madre/progenitoras de membrana amniótica del cordón umbilical
WO2006045105A2 (en) * 2004-10-20 2006-04-27 Vitro Diagnostics, Inc. Generation and differentiation of adult stem cell lines
GB0501129D0 (en) * 2005-01-19 2005-02-23 Ribostem Ltd Method of treatment by administration of RNA
US20080241111A1 (en) * 2005-03-04 2008-10-02 Kyoto University Pluripotent Stem Cell Derived from Cardiac Tissue
US20070093748A1 (en) * 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
JPWO2007010858A1 (ja) * 2005-07-15 2009-01-29 国立大学法人京都大学 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞
US20070054397A1 (en) * 2005-08-26 2007-03-08 Harald Ott Adult cardiac uncommitted progenitor cells
US20080070303A1 (en) * 2005-11-21 2008-03-20 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
RU2308982C2 (ru) * 2005-12-08 2007-10-27 ГУ Научно-исследовательский институт кардиологии Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ кардиологии ТНЦ СО РАМН Способ лечения больных ишемической болезнью сердца, перенесших инфаркт миокарда
FR2896511B1 (fr) * 2006-01-26 2012-10-26 Centre Nat Rech Scient Procede de culture de cellules issues du tissu adipeux et leurs applications.
JP2009531021A (ja) * 2006-02-16 2009-09-03 フォンダッチォーネ・セントロ・サン・ラファエル・デル・モンテ・タボール 骨格筋周囲血管芽細胞および心筋中胚葉性血管芽細胞、それらの単離および使用方法
US20080050347A1 (en) * 2006-08-23 2008-02-28 Ichim Thomas E Stem cell therapy for cardiac valvular dysfunction
EP2079831A2 (en) * 2006-11-07 2009-07-22 Keck Graduate Institute Enriched stem cell and progenitor cell populations, and methods of producing and using such populations

Also Published As

Publication number Publication date
WO2011005930A1 (en) 2011-01-13
RU2642282C1 (ru) 2018-01-24
SG10201406427PA (en) 2014-11-27
KR20120041212A (ko) 2012-04-30
CN102712897B (zh) 2018-07-10
RU2662675C1 (ru) 2018-07-26
RU2583287C2 (ru) 2016-05-10
US20110014161A1 (en) 2011-01-20
ZA201200949B (en) 2018-11-28
EP2451941B1 (en) 2018-06-13
AU2010271394B9 (en) 2015-09-24
EP2451941A4 (en) 2013-06-19
BR112012001107A2 (pt) 2015-09-01
AR077309A1 (es) 2011-08-17
RU2012104553A (ru) 2013-08-20
AU2010271394A1 (en) 2012-01-19
JP5894071B2 (ja) 2016-03-23
CA2767825A1 (en) 2011-01-13
SG176806A1 (en) 2012-01-30
US20160346331A1 (en) 2016-12-01
KR101834800B1 (ko) 2018-03-06
MX2012000493A (es) 2012-06-01
ES2679271T3 (es) 2018-08-23
AU2010271394B2 (en) 2015-09-17
CN102712897A (zh) 2012-10-03
EP2451941A1 (en) 2012-05-16
PL2451941T3 (pl) 2018-10-31
JP2012532609A (ja) 2012-12-20

Similar Documents

Publication Publication Date Title
IL256517A (en) Modified factor ix, and preparations, methods and uses for gene transfer to cells, organs and tissues
WO2010111409A3 (en) Pluripotent stem cells
MY193806A (en) Affinity-oligonucleotide conjugates and uses thereof
MX2012005782A (es) Procedimientos, composiciones y kits de liofilizacion.
CO6561839A2 (es) Alteracion genómica dirigida
WO2015002724A3 (en) SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
WO2011139688A3 (en) Methods for generating cardiomyocytes
IN2012DN02046A (es)
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
MY159971A (en) Multipotent/pluripotent cells and methods
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
MX2012011543A (es) Tratamiento de sarcoidosis empleando celulas madre placentarias.
ZA201202685B (en) Methods of preparing mesenchymal stem cells,compositions and kit thereof
WO2010141417A3 (en) Systems and methods for impairing smooth muscle tissue function
IN2012DN00581A (es)
MX2013004123A (es) Composiciones antitusigenas que comprenden memantina.
SG11201405875PA (en) Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells
WO2012003465A3 (en) Scaffold-free three dimensional nerve fibroblast constructs
MX356178B (es) Uso de azucares en matriz de estabilizacion y composiciones solidas.
MY161601A (en) Films and compositions comprising the same
EP2387609A4 (en) Nonembryonic stem cells and their use
WO2011100286A3 (en) Compositions and methods of generating a differentiated mesodermal cell
PT3551748T (pt) Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações
MX338100B (es) Celulas derivadas de tejido cardiaco.
EP2435558A4 (en) PRODUCTION OF HEAVY INDUCED PLURIPOTENT STEM CELLS GENERALLY CORRECTED

Legal Events

Date Code Title Description
FG Grant or registration